Botanical species · safety record

Cheilocostus speciosus

The EFSA Compendium of Botanicals holds 7 constituent measurements and 1 adverse-effect record for Cheilocostus speciosus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Cheilocostus speciosus (J.König) C.Specht

7Constituent measurements

1Safety records

6Cited sources

0Licensed products (Canada)

Also recorded as

Costus speciosus (J.König) Sm.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Costunolide	Roots and other underground parts	Solvent extraction	—	—	Resolve DOI
Saponins	Roots and other underground parts	Solvent extraction	—	Mass Spectroscopy and hyphenated methods without chromatography	Resolve DOI
1,8-cineole	Roots and other underground parts	Essential oil	10.7 Percent	Unspecified	No resolvable identifier
Alkaloids	Roots and other underground parts	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Saponins	Roots and other underground parts	Solvent extraction	≥ 0.7 Percent	Chromatographic tests	No resolvable identifier
Saponins	Roots and other underground parts	Solvent extraction	≤ 2.5 Percent	Chromatographic tests	No resolvable identifier
Saponins	Roots and other underground parts	Solvent extraction	—	Phytochemical screening	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Reproductive	Uterus	Roots and other underground parts	—	Rat (as animal)	Reproduction toxicity	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Gunatilaka, A. A. L., Sotheeswaran, S., Balasubramaniam, S. Economically useful plants of Sri Lanka. II. Commercially important steroidal sapogenins from Sri Lanka plants. Journal of the National Science Council of Sri Lanka, 1978, p. 121-128.
Tewari, P. V., Chaturvedi, C., Pandey, V. B. Antifertility activity of Costus speciosus. Indian journal of pharmacy, 1973, p. 114-115.
Sharma, M. L., Nigam, M. C., Hande, K. L. Essential oil of Costus speciosus. Perfumery and essential oil record, 1963, p. 579-580.
Dadsena, Rakesh., Sahu, Nitish Kumar., Agrwal, Shirish., Kumar, Anil. Phytochemical analysis of three endangered plants (Costus specious, Gloriossa superba Linn and Rauvolfia serpentine (Linn) Benth) from Kanker district of Chhattisgarh, India. Bioscan, 2013, p. 655-659.
Eliza, James., Daisy, Pitchai., Ignacimuthu, Savarimuthu., Duraipandiyan, Veeramuthu. Normo-glycemic and hypolipidemic effect of costunolide isolated from Costus speciosus (Koen ex. Retz.)Sm. in streptozotocin-induced diabetic rats. CHEMICO-BIOLOGICAL INTERACTIONS, 2009, vol. 179, no. 2-3, p. 329-334. DOI
Meagher, LP., Smith, BL., Wilkins, AL. Metabolism of diosgenin-derived saponins: implications for hepatogenous photosensitization diseases in ruminants. ANIMAL FEED SCIENCE AND TECHNOLOGY, 2001, vol. 91, no. 3-4, p. 157-170. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature